Innovative AI Platform Deep Genomics has developed a cutting-edge AI foundation model platform focused on genomics and RNA biology, creating opportunities to offer advanced AI, machine learning, and data analytics solutions tailored to their deep scientific needs.
Expanding Leadership Recent high-profile board appointments and leadership hires indicate strategic growth and a focus on strengthening executive and scientific talent, suggesting potential for collaborations on leadership insights or executive training services.
Recent Product Launches The launch of proprietary AI models like BigRNA, DeepADAR, and REPRESS demonstrates an ongoing commitment to innovation, opening avenues to introduce complementary tools, data management solutions, or customization services that enhance their AI capabilities.
Strong Investment Backing With over $761 million in funding and revenue estimates between $10M and $25M, Deep Genomics is positioned for rapid growth and could benefit from partnership opportunities in biotech infrastructure, cloud computing, and AI technology scaling.
Biotech Industry Focus Operating within the biotechnology research sector with a focus on genetic therapies and disease mechanisms, Deep Genomics offers potential sales opportunities in laboratory automation, research tools, and specialized biotech software solutions tailored to genomic medicine.
$10M$25M
$1M
$10M$25M
$1M$10M
$1M$10M
$1M
$25M$50MDeep Genomics uses 8 technology products and services including Kubeflow, Zendesk, TensorFlow, and more. Explore Deep Genomics's tech stack below.
| Deep Genomics Email Formats | Percentage |
| First@deepgenomics.com | 80% |
| First.Last@deepgenomics.com | 14% |
| Last@deepgenomics.com | 6% |
Biotechnology ResearchOntario, Canada51-200 Employees
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.
Company Overview
Media & News
Funding & FinancialsDeep Genomics has raised a total of $761M of funding over 6 rounds. Their latest funding round was raised on Jul 28, 2021 in the amount of $180Mas a Series C.
Deep Genomics's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsDeep Genomics has raised a total of $761M of funding over 6 rounds. Their latest funding round was raised on Jul 28, 2021 in the amount of $180Mas a Series C.
Deep Genomics's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com